Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Butow, P. N.
Right arrow Articles by Dunn, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Butow, P. N.
Right arrow Articles by Dunn, S. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 17, Issue 7 (July), 1999: 2256
© 1999 American Society for Clinical Oncology

Psychosocial Predictors of Survival in Metastatic Melanoma

Phyllis N. Butow, Alan S. Coates, Stewart M. Dunn

From the Medical Psychology Unit and Department of Cancer Medicine, University of Sydney, Sydney, and Sydney Melanoma Unit, Royal Prince Alfred Hospital, Camperdown, Australia.

Address reprint requests to Phyllis Butow, PhD, Medical Psychology Unit, Royal Prince Alfred Hospital, Camperdown NSW 2050, Australia; email medpsych{at}mail.usyd.edu.au

PURPOSE: Research interest in psychosocial predictors of the onset and course of cancer has been active since the 1950s. However, results have been contradictory and the literature is noted for methodologic weaknesses. In this prospective study, we aimed to systematically obtain data on psychosocial factors associated with human response to illness.

PATIENTS AND METHODS: One hundred twenty-five patients with metastatic melanoma completed questionnaires measuring cognitive appraisal of threat, coping, psychologic adjustment, perceived aim of treatment, social support, and quality of life (QOL). Questionnaires were completed, where possible, every 3 months for 2 years after diagnosis. Survival was measured from date of study entry to date of death or was censored at the date of last follow-up for surviving patients.

RESULTS: In a multivariate Cox regression analysis of baseline data, which controlled for demographic and disease predictors, the psychologic variables of perceived aim of treatment (P < .001), minimization (P < .05), and anger (P < .05) were independently predictive of survival. Patients who were married (P < .01) and who reported a better QOL (P < .05) also survived longer.

CONCLUSION: The prognostic significance of psychologic and QOL scores remained after allowance for conventional prognostic factors. If these associations reflect an early perception by the patient or doctor of disease progression, then measures are at least valuable early indicators of such progression. If psychologic processes have a more direct influence on the course of the underlying illness, then it may be possible to manipulate them for therapeutic effect. We are now conducting a randomized controlled trial of a psychologic intervention to further elucidate these issues.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
JCOHome page
E. H. Boesen, S. H. Boesen, K. Frederiksen, L. Ross, K. Dahlstrom, G. Schmidt, J. Naested, C. Krag, and C. Johansen
Survival After a Psychoeducational Intervention for Patients With Cutaneous Malignant Melanoma: A Replication Study
J. Clin. Oncol., December 20, 2007; 25(36): 5698 - 5703.
[Abstract] [Full Text] [PDF]


Home page
AM J HOSP PALLIAT CAREHome page
Ying Guo, C. LeDay-Jacobs, J. L. Palmer, and E. Bruera
Psychosocial Assessment of Patients Who Have Undergone Inpatient Cancer Rehabilitation
American Journal of Hospice and Palliative Medicine, June 1, 2007; 24(3): 196 - 201.
[Abstract] [PDF]


Home page
JCOHome page
D. T. Eton, D. L. Fairclough, D. Cella, S. E. Yount, P. Bonomi, and D. H. Johnson
Early Change in Patient-Reported Health During Lung Cancer Chemotherapy Predicts Clinical Outcomes Beyond Those Predicted by Baseline Report: Results From Eastern Cooperative Oncology Group Study 5592
J. Clin. Oncol., April 15, 2003; 21(8): 1536 - 1543.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D.F. Roychowdhury, A. Hayden, and A.M. Liepa
Health-Related Quality-of-Life Parameters as Independent Prognostic Factors in Advanced or Metastatic Bladder Cancer
J. Clin. Oncol., February 15, 2003; 21(4): 673 - 678.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
M. Petticrew, R. Bell, and D. Hunter
Influence of psychological coping on survival and recurrence in people with cancer: systematic review
BMJ, November 9, 2002; 325(7372): 1066 - 1066.
[Abstract] [Full Text] [PDF]


Home page
GerontologistHome page
L. K. George
Research Design in End-of-Life Research: State of Science
Gerontologist, October 1, 2002; 42(90003): 86 - 98.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Samur and P. Butow
Prognosis of Metastatic Melanoma: Where Are the Details?
J. Clin. Oncol., December 1, 1999; 17(12): 3856 - 3860.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 1999 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online